{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+1+-+Group+1%2F2+Placebo&page=8", "query": { "intervention": "Cohort 1 - Group 1/2 Placebo", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 189, "total_pages": 19, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+1+-+Group+1%2F2+Placebo&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+1+-+Group+1%2F2+Placebo&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T10:03:59.561Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06489548", "title": "Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dementia", "Alzheimers Disease", "Mild Cognitive Impairment Due to Alzheimer's Disease" ], "interventions": [ { "name": "Foralumab TZLS-401 50 µg", "type": "DRUG" }, { "name": "Foralumab TZLS-401 100 µg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2025-09-16", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06489548" }, { "nct_id": "NCT01240915", "title": "A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "MultiStem low dose", "type": "DRUG" }, { "name": "MultiStem high dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2011-02", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-02-23", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 37, "location_summary": "San Francisco, California • Lafayette, Colorado • Lakewood, Colorado + 24 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Lafayette", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Littleton", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01240915" }, { "nct_id": "NCT03663335", "title": "Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "CFZ533 - Cohort 1/Cohort 2", "type": "BIOLOGICAL" }, { "name": "Mycophenolate Mofetil (MMF)", "type": "DRUG" }, { "name": "Corticosteroids (CS)", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Induction therapy: basiliximab", "type": "DRUG" }, { "name": "Induction therapy: rabbit anti-thymocyte globulin (rATG)", "type": "DRUG" }, { "name": "Maintenance population: EC-MPS", "type": "DRUG" }, { "name": "Maintenance population: MMF", "type": "DRUG" }, { "name": "Placebo 1 mL", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 418, "start_date": "2018-11-28", "completion_date": "2021-10-29", "has_results": true, "last_update_posted_date": "2026-03-23", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 15, "location_summary": "Los Angeles, California • San Francisco, California • Aurora, Colorado + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03663335" }, { "nct_id": "NCT03142568", "title": "Safety of Sildenafil in Premature Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Sildenafil", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "28 Days", "sex": "ALL", "summary": "7 Days to 28 Days" }, "enrollment_count": 109, "start_date": "2018-04-02", "completion_date": "2025-03-01", "has_results": true, "last_update_posted_date": "2026-03-30", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • Jacksonville, Florida • Chicago, Illinois + 10 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03142568" }, { "nct_id": "NCT05926765", "title": "A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands" ], "interventions": [ { "name": "AAV2-hAQP1 Concentration 1", "type": "GENETIC" }, { "name": "AAV2-hAQP1 Concentration 2", "type": "GENETIC" }, { "name": "Placebo", "type": "OTHER" }, { "name": "AAV2-hAQP1 Concentration 3", "type": "GENETIC" }, { "name": "AAV2-hAQP1 Concentration 4", "type": "GENETIC" } ], "intervention_types": [ "GENETIC", "OTHER" ], "sponsor": "MeiraGTx, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 290, "start_date": "2023-06-13", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 18, "location_summary": "Gilbert, Arizona • Duarte, California • Miami, Florida + 14 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05926765" }, { "nct_id": "NCT02654626", "title": "A Multiple Ascending Dose Study of KBP-7072 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "KBP-7072", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "KBP Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2015-10", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2024-02-23", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 1, "location_summary": "Secaucus, New Jersey", "locations": [ { "city": "Secaucus", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02654626" }, { "nct_id": "NCT07475546", "title": "Combination Gerotherapeutic Interventions for Healthspan Improvement", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthspan Improvement", "Aging", "Longevity" ], "interventions": [ { "name": "Rapamycin", "type": "DRUG" }, { "name": "Naltrexone", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "NAD+", "type": "DRUG" }, { "name": "GSH", "type": "DRUG" }, { "name": "Infinite Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo/control", "type": "DRUG" }, { "name": "B12", "type": "DIETARY_SUPPLEMENT" }, { "name": "Intervention: Guided Meditation Program", "type": "BEHAVIORAL" }, { "name": "Control: Podcast Listening Activity", "type": "BEHAVIORAL" }, { "name": "Control: Standard Exercise Regimen", "type": "BEHAVIORAL" }, { "name": "Intervention: Structured Exercise Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT", "BEHAVIORAL" ], "sponsor": "AgelessRx", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "60 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2025-07-23", "completion_date": "2026-04", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07475546" }, { "nct_id": "NCT03140527", "title": "Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer", "Cystic Fibrosis" ], "interventions": [ { "name": "PTI-801", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PTI-808", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Proteostasis Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 171, "start_date": "2017-04-10", "completion_date": "2020-02-27", "has_results": false, "last_update_posted_date": "2020-04-30", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Stanford, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Altamonte Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03140527" }, { "nct_id": "NCT07187141", "title": "Nasal Protollin in Early Symptomatic Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer Disease (AD)" ], "interventions": [ { "name": "Protollin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2021-11-18", "completion_date": "2023-02-21", "has_results": false, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07187141" }, { "nct_id": "NCT02565511", "title": "A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alzheimers Disease" ], "interventions": [ { "name": "CAD106 Immunotherapy", "type": "BIOLOGICAL" }, { "name": "Placebo to CAD106", "type": "OTHER" }, { "name": "CNP520", "type": "DRUG" }, { "name": "Placebo to CNP520", "type": "OTHER" }, { "name": "Alum", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "60 Years to 75 Years" }, "enrollment_count": 480, "start_date": "2015-11-30", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2021-07-08", "last_synced_at": "2026-10-14T10:03:59.561Z", "location_count": 78, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 67 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02565511" } ] }